Takeda Reports First Quarter FY2018 Results

Takeda Pharmaceutical Company Limited (TOKYO:4502):. Underlying Revenue growth +6.4% with growth in every region. Underlying Revenue grew +6.4%, led by Takeda's Growth Drivers (Gastroenterology, Oncology, Neuroscience and Emerging Markets) ...

from Google Alert - Business https://ift.tt/2OuWtZ3
Takeda Pharmaceutical Company Limited (TOKYO:4502):. Underlying Revenue growth +6.4% with growth in every region. Underlying Revenue grew +6.4%, led by Takeda's Growth Drivers (Gastroenterology, Oncology, Neuroscience and Emerging Markets) ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize